Dr. Raman Tuli
Elementy, w których Dr. Raman Tuli uczestniczy
sobota 26 czerwiec, 2021
Authors: Raman Tuli, 1.Carlos Quezada Ruiz, 2.David Silverman, 3.Vaibhavi Patel, 4.Karen Basu, 5.Hugh Lin. Author Disclosure Block: R. Tuli: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Hoffman Laroche Ltd. Any direct financial payments including receipt of honoraria; Description of relationship(s); Consultant. Funded grants or clinical trials; Name of for-profit or no...
niedziela 27 czerwiec, 2021
Authors: Raman Tuli, Peter A. Campochiaro, Natasha Singh, David Kardatzke, Steven Blotner, Shienal Patel, Giulio Barteselli. Disclosure Block: R. Tuli: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Hoffmann La Roche. Any direct financial payments including receipt of honoraria; Description of relationship(s); Consultant. Funded grants or clinical trials; Name of for-profit or...
piątek 16 czerwiec, 2023
Authors: Raman Tuli. University of Ottawa.Author Disclosures: R. Tuli: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); Advisary Board Apellis. Funded grants or Clinical Trials; Name of for-profit or not-for-profit organization(s); Clinical Trial Apellis. Abstract Body: Purpose: Geographi...
piątek 20 czerwiec, 2025
Author’s Name(s): Raman Tuli, Jeffrey Heier, Nathan Steinle, David Boyer, Ashkan Abbey, David Eichenbaum, Frank Holz, Mathew MacCumber, Caroline Baumal, Charles WykoffAuthor’s Disclosure Block: Raman Tuli: Bayer, Roche, Apotex, Membership on an advisory panel, standing committee or board of directors; Jeffrey Heier: consultant: 4DMT, AbbVie, Adverum, Affamed, AGTC, Akouos, Alimera Sciences, Allgenesis, Alzheon, American Genomics, Annexon, Apellis, Ascl...